Serum SCCA as an Early Indicator of Recurrence in Cervical Cancer.

International journal of radiation oncology, biology, physics(2021)

Cited 0|Views0
No score
Abstract
For patients with elevated pre-treatment serum SCCA, surveillance serum SCCA is an inexpensive and accessible test with high specificity and negative predictive value for recurrence. Surveillance of serum SCCA is of limited utility in patients with normal pre-treatment values.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined